Reshape ApS
CVR number: 40056173
Østbanegade 55, 2100 København Ø
mnm@reshapebiotech.com
tel: 42921548
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 356.36 | 593.49 | 942.95 | 1 968.77 | 1 728.93 |
| Employee benefit expenses | -53.91 | - 601.64 | -3 271.45 | -7 040.03 | -13 759.16 |
| Total depreciation | - 393.99 | ||||
| EBIT | 302.45 | -8.15 | -2 328.50 | -5 071.26 | -12 424.23 |
| Other financial income | 1.24 | 35.56 | 263.58 | ||
| Other financial expenses | -0.30 | -4.21 | -29.61 | - 446.78 | -61.37 |
| Pre-tax profit | 302.15 | -12.36 | -2 356.86 | -5 482.48 | -12 222.02 |
| Income taxes | -67.52 | 64.64 | 707.66 | 843.93 | |
| Net earnings | 234.63 | 52.28 | -1 649.21 | -4 638.55 | -12 222.02 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 231.76 | 1 172.54 | 3 510.45 | 7 346.50 | 14 020.69 |
| Intangible assets total | 231.76 | 1 172.54 | 3 510.45 | 7 346.50 | 14 020.69 |
| Machinery and equipment | 53.33 | ||||
| Tangible assets total | 53.33 | ||||
| Other receivables | 339.60 | 1 247.90 | 1 275.15 | ||
| Investments total | 339.60 | 1 247.90 | 1 275.15 | ||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 67.32 | 151.26 | 268.06 | 282.02 | 2 749.74 |
| Prepayments and accrued income | 159.52 | ||||
| Current other receivables | 24.38 | 68.21 | 342.27 | 661.31 | |
| Current deferred tax assets | 206.97 | 514.34 | 843.93 | 1.00 | |
| Short term receivables total | 91.69 | 358.23 | 850.61 | 1 468.22 | 3 571.57 |
| Cash and bank deposits | 377.36 | 467.81 | 1 439.17 | 18 157.88 | 9 711.12 |
| Cash and cash equivalents | 377.36 | 467.81 | 1 439.17 | 18 157.88 | 9 711.12 |
| Balance sheet total (assets) | 700.81 | 1 998.58 | 6 139.83 | 28 220.50 | 28 631.87 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 10.00 | 40.62 | 540.62 | 540.62 | 540.62 |
| Share premium account | 1 048.38 | 2 491.98 | 2 491.98 | 2 491.98 | |
| Other reserves | 210.76 | 914.58 | 2 738.15 | 5 730.27 | 10 936.14 |
| Retained earnings | - 210.76 | - 708.95 | 1 412.47 | 22 770.17 | 23 311.41 |
| Profit of the financial year | 234.63 | 52.28 | -1 649.21 | -4 638.55 | -12 222.02 |
| Shareholders equity total | 244.63 | 1 346.91 | 5 534.02 | 26 894.49 | 25 058.13 |
| Provisions | 50.99 | 193.31 | |||
| Non-current owed to group member | 300.00 | 300.00 | |||
| Non-current owed to participating | 12.00 | ||||
| Non-current liabilities total | 312.00 | 300.00 | |||
| Advances received | 53.85 | ||||
| Current trade creditors | 6.08 | 28.38 | 155.80 | 88.24 | 9.71 |
| Short-term deferred tax liabilities | 16.53 | ||||
| Other non-interest bearing current liabilities | 16.73 | 129.97 | 325.66 | 490.29 | 524.85 |
| Accruals and deferred income | 124.35 | 747.48 | 3 039.17 | ||
| Current liabilities total | 93.19 | 158.35 | 605.81 | 1 326.01 | 3 573.73 |
| Balance sheet total (liabilities) | 700.81 | 1 998.58 | 6 139.83 | 28 220.50 | 28 631.87 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.